Please note there are further questions under development for this guideline and they will be released for public consultation and published in a staged approach. To be notified about updates, please email guidelines (at) cancer.org.au.
Clinical practice guidelines for the prevention and diagnosis of lung cancer
Screening and early detection
- In people at risk of lung cancer, does population based screening with chest radiography reduce mortality?
Diagnosis and staging
- In people undergoing lung cancer evaluation, does concurrent diagnosis and staging provide greater benefit for patient outcomes compared to sequential testing for diagnosis followed by staging?
- For patients undergoing workup for known or suspected lung cancer, what is the optimal timing of PET/CT? Before or after tissue biopsy confirmation?
- Does routine follow-up improve patient outcomes in people who have curative intent treatments for lung cancer?
- What are the optimal follow-up tests for people with lung cancer who have had curative intent treatment?
- What is the optimal model (provider) of care for the follow up of people with lung cancer who have had curative intent treatment?
Questions under development
- What is the most effective way to manage small solid, sub-solid and non-solid nodules?
- For suspected lung cancer in the periphery of the lung (peripheral pulmonary lesions), what is the most effective diagnostic modality?
- Guideline development process
- List of clinical questions
- Working party members and contributors
- Conflict of interest register